Investigating how different T cell responses react to various tuberculosis antigens
Mechanistic investigation of differential T cell responses to distinct Mycobacterium tuberculosis antigens
This study is looking at how certain parts of the tuberculosis bacteria can help boost the immune response from T cells, with the goal of finding better vaccine options to protect people from TB.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10867404 on NIH RePORTER |
What this research studies
This research focuses on understanding how T cells, which are crucial for fighting tuberculosis (TB), respond to different antigens from the bacteria that cause TB. The study aims to identify which specific antigens can enhance T cell responses and potentially lead to better vaccines. By analyzing the genetic diversity of the TB bacteria, researchers hope to discover new vaccine targets that can improve the effectiveness of TB prevention. Patients may benefit from advancements in TB vaccines that could arise from this work.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of tuberculosis infection or those who have been diagnosed with latent TB.
Not a fit: Patients who are already receiving effective treatment for active tuberculosis or those with no risk factors for TB may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines against tuberculosis, significantly reducing the incidence of the disease.
How similar studies have performed: Previous research has shown promise in developing TB vaccines targeting T cell responses, indicating that this approach has potential for success.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Howard, Zachary — University of California, San Francisco
- Study coordinator: Howard, Zachary
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.